Global Flu (Influenza) Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Page: 113
Published Date: 09 Jan 2024
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global Flu (Influenza) Vaccine market size was valued at USD 5664.4 million in 2023 and is forecast to a readjusted size of USD 7836.7 million by 2030 with a CAGR of 4.7% during review period.
Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Flu (Influenza) Vaccine industry chain, the market status of For Children (6 months to 3 years) (Split Influenza Vaccine, Pandemic Influenza Vaccine), For Adults and Children over 3 years (Split Influenza Vaccine, Pandemic Influenza Vaccine), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Flu (Influenza) Vaccine.
Regionally, the report analyzes the Flu (Influenza) Vaccine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Flu (Influenza) Vaccine market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Flu (Influenza) Vaccine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Flu (Influenza) Vaccine industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Split Influenza Vaccine, Pandemic Influenza Vaccine).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Flu (Influenza) Vaccine market.
Regional Analysis: The report involves examining the Flu (Influenza) Vaccine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Flu (Influenza) Vaccine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Flu (Influenza) Vaccine:
Company Analysis: Report covers individual Flu (Influenza) Vaccine manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Flu (Influenza) Vaccine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (For Children (6 months to 3 years), For Adults and Children over 3 years).
Technology Analysis: Report covers specific technologies relevant to Flu (Influenza) Vaccine. It assesses the current state, advancements, and potential future developments in Flu (Influenza) Vaccine areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Flu (Influenza) Vaccine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Flu (Influenza) Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Split Influenza Vaccine
Pandemic Influenza Vaccine
Subunit Influenza Vaccine
Quadrivalent Influenza Vaccine
Market segment by Application
For Children (6 months to 3 years)
For Adults and Children over 3 years
Major players covered
Hualan Bio
CCBIO
Aleph Biomedical
SANOFI
Adimmune
ZYAK
SINOVAC
Changsheng Biological
SIOBP
GSK
Aimei Hissen
Tianyuan Bio-pharma(Novartis)
Simcere Vaxtec
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Flu (Influenza) Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Flu (Influenza) Vaccine, with price, sales, revenue and global market share of Flu (Influenza) Vaccine from 2019 to 2024.
Chapter 3, the Flu (Influenza) Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Flu (Influenza) Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Flu (Influenza) Vaccine market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Flu (Influenza) Vaccine.
Chapter 14 and 15, to describe Flu (Influenza) Vaccine sales channel, distributors, customers, research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Flu (Influenza) Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Flu (Influenza) Vaccine Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Split Influenza Vaccine
1.3.3 Pandemic Influenza Vaccine
1.3.4 Subunit Influenza Vaccine
1.3.5 Quadrivalent Influenza Vaccine
1.4 Market Analysis by Application
1.4.1 Overview: Global Flu (Influenza) Vaccine Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 For Children (6 months to 3 years)
1.4.3 For Adults and Children over 3 years
1.5 Global Flu (Influenza) Vaccine Market Size & Forecast
1.5.1 Global Flu (Influenza) Vaccine Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Flu (Influenza) Vaccine Sales Quantity (2019-2030)
1.5.3 Global Flu (Influenza) Vaccine Average Price (2019-2030)
2.1 Hualan Bio
2.1.1 Hualan Bio Details
2.1.2 Hualan Bio Major Business
2.1.3 Hualan Bio Flu (Influenza) Vaccine Product and Services
2.1.4 Hualan Bio Flu (Influenza) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Hualan Bio Recent Developments/Updates
2.2 CCBIO
2.2.1 CCBIO Details
2.2.2 CCBIO Major Business
2.2.3 CCBIO Flu (Influenza) Vaccine Product and Services
2.2.4 CCBIO Flu (Influenza) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 CCBIO Recent Developments/Updates
2.3 Aleph Biomedical
2.3.1 Aleph Biomedical Details
2.3.2 Aleph Biomedical Major Business
2.3.3 Aleph Biomedical Flu (Influenza) Vaccine Product and Services
2.3.4 Aleph Biomedical Flu (Influenza) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Aleph Biomedical Recent Developments/Updates
2.4 SANOFI
2.4.1 SANOFI Details
2.4.2 SANOFI Major Business
2.4.3 SANOFI Flu (Influenza) Vaccine Product and Services
2.4.4 SANOFI Flu (Influenza) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 SANOFI Recent Developments/Updates
2.5 Adimmune
2.5.1 Adimmune Details
2.5.2 Adimmune Major Business
2.5.3 Adimmune Flu (Influenza) Vaccine Product and Services
2.5.4 Adimmune Flu (Influenza) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Adimmune Recent Developments/Updates
2.6 ZYAK
2.6.1 ZYAK Details
2.6.2 ZYAK Major Business
2.6.3 ZYAK Flu (Influenza) Vaccine Product and Services
2.6.4 ZYAK Flu (Influenza) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 ZYAK Recent Developments/Updates
2.7 SINOVAC
2.7.1 SINOVAC Details
2.7.2 SINOVAC Major Business
2.7.3 SINOVAC Flu (Influenza) Vaccine Product and Services
2.7.4 SINOVAC Flu (Influenza) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 SINOVAC Recent Developments/Updates
2.8 Changsheng Biological
2.8.1 Changsheng Biological Details
2.8.2 Changsheng Biological Major Business
2.8.3 Changsheng Biological Flu (Influenza) Vaccine Product and Services
2.8.4 Changsheng Biological Flu (Influenza) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Changsheng Biological Recent Developments/Updates
2.9 SIOBP
2.9.1 SIOBP Details
2.9.2 SIOBP Major Business
2.9.3 SIOBP Flu (Influenza) Vaccine Product and Services
2.9.4 SIOBP Flu (Influenza) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 SIOBP Recent Developments/Updates
2.10 GSK
2.10.1 GSK Details
2.10.2 GSK Major Business
2.10.3 GSK Flu (Influenza) Vaccine Product and Services
2.10.4 GSK Flu (Influenza) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 GSK Recent Developments/Updates
2.11 Aimei Hissen
2.11.1 Aimei Hissen Details
2.11.2 Aimei Hissen Major Business
2.11.3 Aimei Hissen Flu (Influenza) Vaccine Product and Services
2.11.4 Aimei Hissen Flu (Influenza) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Aimei Hissen Recent Developments/Updates
2.12 Tianyuan Bio-pharma(Novartis)
2.12.1 Tianyuan Bio-pharma(Novartis) Details
2.12.2 Tianyuan Bio-pharma(Novartis) Major Business
2.12.3 Tianyuan Bio-pharma(Novartis) Flu (Influenza) Vaccine Product and Services
2.12.4 Tianyuan Bio-pharma(Novartis) Flu (Influenza) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Tianyuan Bio-pharma(Novartis) Recent Developments/Updates
2.13 Simcere Vaxtec
2.13.1 Simcere Vaxtec Details
2.13.2 Simcere Vaxtec Major Business
2.13.3 Simcere Vaxtec Flu (Influenza) Vaccine Product and Services
2.13.4 Simcere Vaxtec Flu (Influenza) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Simcere Vaxtec Recent Developments/Updates
3.1 Global Flu (Influenza) Vaccine Sales Quantity by Manufacturer (2019-2024)
3.2 Global Flu (Influenza) Vaccine Revenue by Manufacturer (2019-2024)
3.3 Global Flu (Influenza) Vaccine Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Flu (Influenza) Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Flu (Influenza) Vaccine Manufacturer Market Share in 2023
3.4.2 Top 6 Flu (Influenza) Vaccine Manufacturer Market Share in 2023
3.5 Flu (Influenza) Vaccine Market: Overall Company Footprint Analysis
3.5.1 Flu (Influenza) Vaccine Market: Region Footprint
3.5.2 Flu (Influenza) Vaccine Market: Company Product Type Footprint
3.5.3 Flu (Influenza) Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Flu (Influenza) Vaccine Market Size by Region
4.1.1 Global Flu (Influenza) Vaccine Sales Quantity by Region (2019-2030)
4.1.2 Global Flu (Influenza) Vaccine Consumption Value by Region (2019-2030)
4.1.3 Global Flu (Influenza) Vaccine Average Price by Region (2019-2030)
4.2 North America Flu (Influenza) Vaccine Consumption Value (2019-2030)
4.3 Europe Flu (Influenza) Vaccine Consumption Value (2019-2030)
4.4 Asia-Pacific Flu (Influenza) Vaccine Consumption Value (2019-2030)
4.5 South America Flu (Influenza) Vaccine Consumption Value (2019-2030)
4.6 Middle East and Africa Flu (Influenza) Vaccine Consumption Value (2019-2030)
5.1 Global Flu (Influenza) Vaccine Sales Quantity by Type (2019-2030)
5.2 Global Flu (Influenza) Vaccine Consumption Value by Type (2019-2030)
5.3 Global Flu (Influenza) Vaccine Average Price by Type (2019-2030)
6.1 Global Flu (Influenza) Vaccine Sales Quantity by Application (2019-2030)
6.2 Global Flu (Influenza) Vaccine Consumption Value by Application (2019-2030)
6.3 Global Flu (Influenza) Vaccine Average Price by Application (2019-2030)
7.1 North America Flu (Influenza) Vaccine Sales Quantity by Type (2019-2030)
7.2 North America Flu (Influenza) Vaccine Sales Quantity by Application (2019-2030)
7.3 North America Flu (Influenza) Vaccine Market Size by Country
7.3.1 North America Flu (Influenza) Vaccine Sales Quantity by Country (2019-2030)
7.3.2 North America Flu (Influenza) Vaccine Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8.1 Europe Flu (Influenza) Vaccine Sales Quantity by Type (2019-2030)
8.2 Europe Flu (Influenza) Vaccine Sales Quantity by Application (2019-2030)
8.3 Europe Flu (Influenza) Vaccine Market Size by Country
8.3.1 Europe Flu (Influenza) Vaccine Sales Quantity by Country (2019-2030)
8.3.2 Europe Flu (Influenza) Vaccine Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9.1 Asia-Pacific Flu (Influenza) Vaccine Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Flu (Influenza) Vaccine Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Flu (Influenza) Vaccine Market Size by Region
9.3.1 Asia-Pacific Flu (Influenza) Vaccine Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Flu (Influenza) Vaccine Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10.1 South America Flu (Influenza) Vaccine Sales Quantity by Type (2019-2030)
10.2 South America Flu (Influenza) Vaccine Sales Quantity by Application (2019-2030)
10.3 South America Flu (Influenza) Vaccine Market Size by Country
10.3.1 South America Flu (Influenza) Vaccine Sales Quantity by Country (2019-2030)
10.3.2 South America Flu (Influenza) Vaccine Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11.1 Middle East & Africa Flu (Influenza) Vaccine Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Flu (Influenza) Vaccine Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Flu (Influenza) Vaccine Market Size by Country
11.3.1 Middle East & Africa Flu (Influenza) Vaccine Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Flu (Influenza) Vaccine Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12.1 Flu (Influenza) Vaccine Market Drivers
12.2 Flu (Influenza) Vaccine Market Restraints
12.3 Flu (Influenza) Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13.1 Raw Material of Flu (Influenza) Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Flu (Influenza) Vaccine
13.3 Flu (Influenza) Vaccine Production Process
13.4 Flu (Influenza) Vaccine Industrial Chain
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Flu (Influenza) Vaccine Typical Distributors
14.3 Flu (Influenza) Vaccine Typical Customers
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Flu (Influenza) Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Flu (Influenza) Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Hualan Bio Basic Information, Manufacturing Base and Competitors
Table 4. Hualan Bio Major Business
Table 5. Hualan Bio Flu (Influenza) Vaccine Product and Services
Table 6. Hualan Bio Flu (Influenza) Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Hualan Bio Recent Developments/Updates
Table 8. CCBIO Basic Information, Manufacturing Base and Competitors
Table 9. CCBIO Major Business
Table 10. CCBIO Flu (Influenza) Vaccine Product and Services
Table 11. CCBIO Flu (Influenza) Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. CCBIO Recent Developments/Updates
Table 13. Aleph Biomedical Basic Information, Manufacturing Base and Competitors
Table 14. Aleph Biomedical Major Business
Table 15. Aleph Biomedical Flu (Influenza) Vaccine Product and Services
Table 16. Aleph Biomedical Flu (Influenza) Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Aleph Biomedical Recent Developments/Updates
Table 18. SANOFI Basic Information, Manufacturing Base and Competitors
Table 19. SANOFI Major Business
Table 20. SANOFI Flu (Influenza) Vaccine Product and Services
Table 21. SANOFI Flu (Influenza) Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. SANOFI Recent Developments/Updates
Table 23. Adimmune Basic Information, Manufacturing Base and Competitors
Table 24. Adimmune Major Business
Table 25. Adimmune Flu (Influenza) Vaccine Product and Services
Table 26. Adimmune Flu (Influenza) Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Adimmune Recent Developments/Updates
Table 28. ZYAK Basic Information, Manufacturing Base and Competitors
Table 29. ZYAK Major Business
Table 30. ZYAK Flu (Influenza) Vaccine Product and Services
Table 31. ZYAK Flu (Influenza) Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. ZYAK Recent Developments/Updates
Table 33. SINOVAC Basic Information, Manufacturing Base and Competitors
Table 34. SINOVAC Major Business
Table 35. SINOVAC Flu (Influenza) Vaccine Product and Services
Table 36. SINOVAC Flu (Influenza) Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. SINOVAC Recent Developments/Updates
Table 38. Changsheng Biological Basic Information, Manufacturing Base and Competitors
Table 39. Changsheng Biological Major Business
Table 40. Changsheng Biological Flu (Influenza) Vaccine Product and Services
Table 41. Changsheng Biological Flu (Influenza) Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Changsheng Biological Recent Developments/Updates
Table 43. SIOBP Basic Information, Manufacturing Base and Competitors
Table 44. SIOBP Major Business
Table 45. SIOBP Flu (Influenza) Vaccine Product and Services
Table 46. SIOBP Flu (Influenza) Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. SIOBP Recent Developments/Updates
Table 48. GSK Basic Information, Manufacturing Base and Competitors
Table 49. GSK Major Business
Table 50. GSK Flu (Influenza) Vaccine Product and Services
Table 51. GSK Flu (Influenza) Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. GSK Recent Developments/Updates
Table 53. Aimei Hissen Basic Information, Manufacturing Base and Competitors
Table 54. Aimei Hissen Major Business
Table 55. Aimei Hissen Flu (Influenza) Vaccine Product and Services
Table 56. Aimei Hissen Flu (Influenza) Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Aimei Hissen Recent Developments/Updates
Table 58. Tianyuan Bio-pharma(Novartis) Basic Information, Manufacturing Base and Competitors
Table 59. Tianyuan Bio-pharma(Novartis) Major Business
Table 60. Tianyuan Bio-pharma(Novartis) Flu (Influenza) Vaccine Product and Services
Table 61. Tianyuan Bio-pharma(Novartis) Flu (Influenza) Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. Tianyuan Bio-pharma(Novartis) Recent Developments/Updates
Table 63. Simcere Vaxtec Basic Information, Manufacturing Base and Competitors
Table 64. Simcere Vaxtec Major Business
Table 65. Simcere Vaxtec Flu (Influenza) Vaccine Product and Services
Table 66. Simcere Vaxtec Flu (Influenza) Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. Simcere Vaxtec Recent Developments/Updates
Table 68. Global Flu (Influenza) Vaccine Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 69. Global Flu (Influenza) Vaccine Revenue by Manufacturer (2019-2024) & (USD Million)
Table 70. Global Flu (Influenza) Vaccine Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 71. Market Position of Manufacturers in Flu (Influenza) Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 72. Head Office and Flu (Influenza) Vaccine Production Site of Key Manufacturer
Table 73. Flu (Influenza) Vaccine Market: Company Product Type Footprint
Table 74. Flu (Influenza) Vaccine Market: Company Product Application Footprint
Table 75. Flu (Influenza) Vaccine New Market Entrants and Barriers to Market Entry
Table 76. Flu (Influenza) Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 77. Global Flu (Influenza) Vaccine Sales Quantity by Region (2019-2024) & (K Units)
Table 78. Global Flu (Influenza) Vaccine Sales Quantity by Region (2025-2030) & (K Units)
Table 79. Global Flu (Influenza) Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 80. Global Flu (Influenza) Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 81. Global Flu (Influenza) Vaccine Average Price by Region (2019-2024) & (US$/Unit)
Table 82. Global Flu (Influenza) Vaccine Average Price by Region (2025-2030) & (US$/Unit)
Table 83. Global Flu (Influenza) Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 84. Global Flu (Influenza) Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 85. Global Flu (Influenza) Vaccine Consumption Value by Type (2019-2024) & (USD Million)
Table 86. Global Flu (Influenza) Vaccine Consumption Value by Type (2025-2030) & (USD Million)
Table 87. Global Flu (Influenza) Vaccine Average Price by Type (2019-2024) & (US$/Unit)
Table 88. Global Flu (Influenza) Vaccine Average Price by Type (2025-2030) & (US$/Unit)
Table 89. Global Flu (Influenza) Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 90. Global Flu (Influenza) Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 91. Global Flu (Influenza) Vaccine Consumption Value by Application (2019-2024) & (USD Million)
Table 92. Global Flu (Influenza) Vaccine Consumption Value by Application (2025-2030) & (USD Million)
Table 93. Global Flu (Influenza) Vaccine Average Price by Application (2019-2024) & (US$/Unit)
Table 94. Global Flu (Influenza) Vaccine Average Price by Application (2025-2030) & (US$/Unit)
Table 95. North America Flu (Influenza) Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 96. North America Flu (Influenza) Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 97. North America Flu (Influenza) Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 98. North America Flu (Influenza) Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 99. North America Flu (Influenza) Vaccine Sales Quantity by Country (2019-2024) & (K Units)
Table 100. North America Flu (Influenza) Vaccine Sales Quantity by Country (2025-2030) & (K Units)
Table 101. North America Flu (Influenza) Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 102. North America Flu (Influenza) Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 103. Europe Flu (Influenza) Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 104. Europe Flu (Influenza) Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 105. Europe Flu (Influenza) Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 106. Europe Flu (Influenza) Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 107. Europe Flu (Influenza) Vaccine Sales Quantity by Country (2019-2024) & (K Units)
Table 108. Europe Flu (Influenza) Vaccine Sales Quantity by Country (2025-2030) & (K Units)
Table 109. Europe Flu (Influenza) Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 110. Europe Flu (Influenza) Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 111. Asia-Pacific Flu (Influenza) Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 112. Asia-Pacific Flu (Influenza) Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 113. Asia-Pacific Flu (Influenza) Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 114. Asia-Pacific Flu (Influenza) Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 115. Asia-Pacific Flu (Influenza) Vaccine Sales Quantity by Region (2019-2024) & (K Units)
Table 116. Asia-Pacific Flu (Influenza) Vaccine Sales Quantity by Region (2025-2030) & (K Units)
Table 117. Asia-Pacific Flu (Influenza) Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 118. Asia-Pacific Flu (Influenza) Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 119. South America Flu (Influenza) Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 120. South America Flu (Influenza) Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 121. South America Flu (Influenza) Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 122. South America Flu (Influenza) Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 123. South America Flu (Influenza) Vaccine Sales Quantity by Country (2019-2024) & (K Units)
Table 124. South America Flu (Influenza) Vaccine Sales Quantity by Country (2025-2030) & (K Units)
Table 125. South America Flu (Influenza) Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 126. South America Flu (Influenza) Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 127. Middle East & Africa Flu (Influenza) Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 128. Middle East & Africa Flu (Influenza) Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 129. Middle East & Africa Flu (Influenza) Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 130. Middle East & Africa Flu (Influenza) Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 131. Middle East & Africa Flu (Influenza) Vaccine Sales Quantity by Region (2019-2024) & (K Units)
Table 132. Middle East & Africa Flu (Influenza) Vaccine Sales Quantity by Region (2025-2030) & (K Units)
Table 133. Middle East & Africa Flu (Influenza) Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 134. Middle East & Africa Flu (Influenza) Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 135. Flu (Influenza) Vaccine Raw Material
Table 136. Key Manufacturers of Flu (Influenza) Vaccine Raw Materials
Table 137. Flu (Influenza) Vaccine Typical Distributors
Table 138. Flu (Influenza) Vaccine Typical Customers
List of Figures
Figure 1. Flu (Influenza) Vaccine Picture
Figure 2. Global Flu (Influenza) Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Flu (Influenza) Vaccine Consumption Value Market Share by Type in 2023
Figure 4. Split Influenza Vaccine Examples
Figure 5. Pandemic Influenza Vaccine Examples
Figure 6. Subunit Influenza Vaccine Examples
Figure 7. Quadrivalent Influenza Vaccine Examples
Figure 8. Global Flu (Influenza) Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 9. Global Flu (Influenza) Vaccine Consumption Value Market Share by Application in 2023
Figure 10. For Children (6 months to 3 years) Examples
Figure 11. For Adults and Children over 3 years Examples
Figure 12. Global Flu (Influenza) Vaccine Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 13. Global Flu (Influenza) Vaccine Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 14. Global Flu (Influenza) Vaccine Sales Quantity (2019-2030) & (K Units)
Figure 15. Global Flu (Influenza) Vaccine Average Price (2019-2030) & (US$/Unit)
Figure 16. Global Flu (Influenza) Vaccine Sales Quantity Market Share by Manufacturer in 2023
Figure 17. Global Flu (Influenza) Vaccine Consumption Value Market Share by Manufacturer in 2023
Figure 18. Producer Shipments of Flu (Influenza) Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 19. Top 3 Flu (Influenza) Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 20. Top 6 Flu (Influenza) Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 21. Global Flu (Influenza) Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 22. Global Flu (Influenza) Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 23. North America Flu (Influenza) Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 24. Europe Flu (Influenza) Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 25. Asia-Pacific Flu (Influenza) Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 26. South America Flu (Influenza) Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 27. Middle East & Africa Flu (Influenza) Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 28. Global Flu (Influenza) Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 29. Global Flu (Influenza) Vaccine Consumption Value Market Share by Type (2019-2030)
Figure 30. Global Flu (Influenza) Vaccine Average Price by Type (2019-2030) & (US$/Unit)
Figure 31. Global Flu (Influenza) Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 32. Global Flu (Influenza) Vaccine Consumption Value Market Share by Application (2019-2030)
Figure 33. Global Flu (Influenza) Vaccine Average Price by Application (2019-2030) & (US$/Unit)
Figure 34. North America Flu (Influenza) Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 35. North America Flu (Influenza) Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 36. North America Flu (Influenza) Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 37. North America Flu (Influenza) Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 38. United States Flu (Influenza) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Canada Flu (Influenza) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Mexico Flu (Influenza) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Europe Flu (Influenza) Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 42. Europe Flu (Influenza) Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 43. Europe Flu (Influenza) Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 44. Europe Flu (Influenza) Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 45. Germany Flu (Influenza) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. France Flu (Influenza) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. United Kingdom Flu (Influenza) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Russia Flu (Influenza) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Italy Flu (Influenza) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Asia-Pacific Flu (Influenza) Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 51. Asia-Pacific Flu (Influenza) Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 52. Asia-Pacific Flu (Influenza) Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 53. Asia-Pacific Flu (Influenza) Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 54. China Flu (Influenza) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Japan Flu (Influenza) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Korea Flu (Influenza) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. India Flu (Influenza) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Southeast Asia Flu (Influenza) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Australia Flu (Influenza) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. South America Flu (Influenza) Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 61. South America Flu (Influenza) Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 62. South America Flu (Influenza) Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 63. South America Flu (Influenza) Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 64. Brazil Flu (Influenza) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Argentina Flu (Influenza) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. Middle East & Africa Flu (Influenza) Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 67. Middle East & Africa Flu (Influenza) Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 68. Middle East & Africa Flu (Influenza) Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 69. Middle East & Africa Flu (Influenza) Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 70. Turkey Flu (Influenza) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Egypt Flu (Influenza) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Saudi Arabia Flu (Influenza) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. South Africa Flu (Influenza) Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Flu (Influenza) Vaccine Market Drivers
Figure 75. Flu (Influenza) Vaccine Market Restraints
Figure 76. Flu (Influenza) Vaccine Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Flu (Influenza) Vaccine in 2023
Figure 79. Manufacturing Process Analysis of Flu (Influenza) Vaccine
Figure 80. Flu (Influenza) Vaccine Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Hualan Bio CCBIO Aleph Biomedical SANOFI Adimmune ZYAK SINOVAC Changsheng Biological SIOBP GSK Aimei Hissen Tianyuan Bio-pharma(Novartis) Simcere Vaxtec
Related Reports
08 Jan 2023
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
